Skip to main content
logo
Formycon AG (FRA:FYB)
Germany flag Germany · Delayed Price · Currency is EUR
27.95
-1.65 (-5.57%)
At close: Jul 31, 2025, 10:00 PM CET

Intra-Cellular Therapies Revenue

In the year 2024, Formycon AG had annual revenue of 69.67M EUR, down -10.32%. Formycon AG had revenue of 42.78M in the half year ending December 31, 2024, with 72.14% growth.

Revenue
69.67M
Revenue Growth
-10.32%
P/S Ratio
6.70
Revenue / Employee
278.70K
Employees
250
Market Cap
467.03M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202469.67M-8.02M-10.32%
Dec 31, 202377.70M35.20M82.83%
Dec 31, 202242.50M5.88M16.07%
Dec 31, 202136.61M2.32M6.76%
Dec 31, 202034.30M1.14M3.43%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
SAP SE35.89B
Siemens Aktiengesellschaft77.82B
Deutsche Telekom AG120.25B
Allianz SE109.03B
Siemens Energy AG37.44B
Rheinmetall AG10.48B
Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München61.84B
Deutsche Bank Aktiengesellschaft30.07B
Revenue Rankings

Formycon AG News

More News